FDA inspection
Nordic Pharma, Inc.: FDA inspection ending Nov 16, 2023
FDA inspection 1225730 · No Action Indicated (NAI) · Berwyn, PA
Key facts
| Inspection ID | 1225730 |
|---|---|
| Firm | Nordic Pharma, Inc. |
| FEI number | 3011965331 |
| Address | 1205 Westlakes Dr Ste 275 |
| City | Berwyn |
| State | PA |
| ZIP | 19312 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Nov 16, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data